A citation-based method for searching scientific literature

Yanxin Pei, Kun-Wei Liu, Jun Wang, Alexandra Garancher, Ran Tao, Lourdes A Esparza, Donna L Maier, Yoko T Udaka, Najiba Murad, Sorana Morrissy, Huriye Seker-Cin, Sebastian Brabetz, Lin Qi, Mari Kogiso, Simone Schubert, James M Olson, Yoon-Jae Cho, Xiao-Nan Li, John R Crawford, Michael L Levy, Marcel Kool, Stefan M Pfister, Michael D Taylor, Robert J Wechsler-Reya. Cancer Cell 2016
Times Cited: 144



Michelle L Cook Sangar, Laura A Genovesi, Madison W Nakamoto, Melissa J Davis, Sue E Knobluagh, Pengxiang Ji, Amanda Millar, Brandon J Wainwright, James M Olson. Clin Cancer Res 2017
Times Cited: 44




List of shared articles



Times cited

Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures.
Michael Hu, Xin Yi Lei, Jon D Larson, Melissa McAlonis, Kyle Ford, Daniella McDonald, Krystal Mach, Jessica M Rusert, Robert J Wechsler-Reya, Prashant Mali. Biomaterials 2022
0

Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Stefania Bartolini, Alba Ariela Brandes. Cancers (Basel) 2022
0

The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma.
David R Ghasemi, Gudrun Fleischhack, Till Milde, Kristian W Pajtler. Cancers (Basel) 2022
0

Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma.
Raelene Endersby, Jacqueline Whitehouse, Allison Pribnow, Mani Kuchibhotla, Hilary Hii, Brooke Carline, Suresh Gande, Jennifer Stripay, Mathew Ancliffe, Meegan Howlett,[...]. Sci Transl Med 2021
13

TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma.
Rachael E Maynard, Brad Poore, Allison R Hanaford, Khoa Pham, Madison James, Jesse Alt, Youngran Park, Barbara S Slusher, Pablo Tamayo, Jill Mesirov,[...]. Cancer Lett 2021
1

Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma.
Laura A Genovesi, Amanda Millar, Elissa Tolson, Matthew Singleton, Emily Hassall, Marija Kojic, Caterina Brighi, Emily Girard, Clara Andradas, Mani Kuchibhotla,[...]. Genome Med 2021
2

Childhood Malignant Brain Tumors: Balancing the Bench and Bedside.
Colin Thorbinson, John-Paul Kilday. Cancers (Basel) 2021
1

Modeling pediatric medulloblastoma.
Martine F Roussel, Jennifer L Stripay. Brain Pathol 2020
10


Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma.
Jessica M Rusert, Edwin F Juarez, Sebastian Brabetz, James Jensen, Alexandra Garancher, Lianne Q Chau, Silvia K Tacheva-Grigorova, Sameerah Wahab, Yoko T Udaka, Darren Finlay,[...]. Cancer Res 2020
11

Medulloblastoma.
Paul A Northcott, Giles W Robinson, Christian P Kratz, Donald J Mabbott, Scott L Pomeroy, Steven C Clifford, Stefan Rutkowski, David W Ellison, David Malkin, Michael D Taylor,[...]. Nat Rev Dis Primers 2019
201

Medulloblastoma in the age of molecular subgroups: a review.
Kyle Juraschka, Michael D Taylor. J Neurosurg Pediatr 2019
66